Employers at a virtual NJBIA Health Affairs Policy Committee meeting questioned Murphy administration officials for details on when more New Jersey businesses can reopen and what COVID-19 testing precautions need to be followed in their workplaces to keep employees and customers safe. “As we start looking at the reopening of the economy, testing is a […]
Health Affairs Policy Committee
New Jersey Rare Disease Day 2019
Monday, March 11 from 8:30 a.m. – 3:00 p.m. Please join the New Jersey Rare Action Network for a free Rare Disease Day advocacy event. Patients, families, caregivers, medical professionals, industry representatives, and elected officials and their staff are invited to attend to learn about real world advocacy from New Jersey legislators and about the […]
Reminder – NJBIA Health Affairs Policy Committee Meeting, September 7
Health Affairs Policy Committee Meeting Friday. September 7, 2018 9 a.m. – 11:30 a.m. at NJBIA Please join us tomorrow, Friday, September 7, for our Health Affairs Policy Committee meeting. We are pleased to have as our guest speakers Sarah Adelman, Deputy Commissioner, NJ Department of Human Services; Robin Ford, Executive Director, Office of Health […]
Guest Speakers Announced for NJBIA Health Affairs Policy Committee Meeting
Health Affairs Policy Committee Meeting Friday. September 7, 2018 9 a.m. – 11:30 a.m. at NJBIA We are pleased to announce our guest speakers: Sarah Adelman, Deputy Commissioner, NJ Department of Human Services; Robin Ford, Executive Director, Office of Health Care Financing, NJ Department of Health; and Philip Gennace, Assistant Commissioner, NJ Department of Banking […]
Revised Prescriber Gift Ban Released
New Jersey Attorney General Gurbir Grewal has proposed new amendments to the state’s limitations on prescriber compensation from pharmaceutical manufacturers. The limitations, which were enabled by the “Prescriber Gift Ban” (N.J.A.C. 13:45J), were formalized at the beginning of the year during the final days of the Christie administration. The regulations finalized in January prohibit prescribers […]